⌘K
Loading ticker…
As of 2026-08-24, Erasca, Inc. Common Stock (ERAS) has a 3-month relative strength percentile of 95 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 99. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 5.8%, relative volume 0.73×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
ERAS is held by 25 ETFs as of May 2026. Top owner: SCHA at 0.06% weight, $15M notional. Top 3 carry $34M.
Held by 53 ETFs · $454M across latest filings · largest weight 2.19% (BBC).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| SCHASchwab U.S. Small-Cap ETF | 0.06% | $15M | −0.01 pp |
| VTWO | 0.07% | $13M | — |
| VHTVanguard Health Care ETF | 0.03% | $7M | — |
| DWAS | 0.87% | $4M | new |
| VFMO | 0.17% | $3M | — |
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.15% |
| $2M |
| — |
| CANC | 1.08% | $2M | −0.37 pp |
| SCHBSchwab U.S. Broad Market ETF | 0.00% | $2M | — |
| ESML | 0.05% | $1M | new |
| ONEQ | 0.01% | $983K | — |
Showing 10 of 25 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ERAS Jan avg: 32.26% median: -14.39% win: 25% σ: 100.47% n: 4 2022-04-12 → 2026-07-31 | ERAS Feb avg: 8.74% median: 9.99% win: 50% σ: 32.95% n: 4 2022-04-12 → 2026-07-31 | ERAS Mar avg: -2.85% median: -6.72% win: 25% σ: 15.89% n: 4 2022-04-12 → 2026-07-31 | ERAS Apr avg: -9.40% median: -8.31% win: 20% σ: 15.16% n: 5 2022-04-12 → 2026-07-31 | ERAS May avg: 2.89% median: -1.81% win: 40% σ: 20.60% n: 5 2022-04-12 → 2026-07-31 | ERAS Jun avg: 6.33% median: 1.85% win: 60% σ: 20.97% n: 5 2022-04-12 → 2026-07-31 | ERAS Jul avg: 15.00% median: 11.42% win: 60% σ: 18.69% n: 5 2022-04-12 → 2026-07-31 | ERAS Aug avg: 5.11% median: 4.53% win: 50% σ: 12.55% n: 4 2022-04-12 → 2026-07-31 (current) | ERAS Sep avg: -1.04% median: -9.53% win: 25% σ: 27.64% n: 4 2022-04-12 → 2026-07-31 | ERAS Oct avg: 6.97% median: 7.88% win: 75% σ: 9.55% n: 4 2022-04-12 → 2026-07-31 | ERAS Nov avg: 1.85% median: 1.42% win: 50% σ: 24.57% n: 4 2022-04-12 → 2026-07-31 | ERAS Dec avg: -3.13% median: 2.56% win: 50% σ: 31.05% n: 4 2022-04-12 → 2026-07-31 |